HLA-B*14 allele predicts HIV-1 mother-to-child-transmission, in Salvador, Brazil.

Autor: Angulo JMC; Laboratório de Pesquisa em Infectologia, Salvador, BA, Brazil; Universidade Federal da Bahia, Escola de Medicina Salvador, Complexo Hospitalar Prof. Edgard Santos, Salvador, BA, Brazil., Cuesta TAC; Universidade Federal da Bahia, Escola de Medicina Salvador, Complexo Hospitalar Prof. Edgard Santos, Salvador, BA, Brazil., Menezes EP; Universidade Federal da Bahia, Escola de Medicina Salvador, Complexo Hospitalar Prof. Edgard Santos, Salvador, BA, Brazil., Pedroso C; Laboratório de Pesquisa em Infectologia, Salvador, BA, Brazil., Brites C; Laboratório de Pesquisa em Infectologia, Salvador, BA, Brazil. Electronic address: crbrites@gmail.com.

Publikováno v: The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases [Braz J Infect Dis] 2019 Mar - Apr; Vol. 23 (2), pp. 71-78. Date of Electronic Publication: 2019 May 18.

Full-length sequences of 3 HLA-B alleles, B*07:05:01:01, B*14:01:01 and B*18:02, confirmed by cloning and sequencing.

Autor: Li Z; Immunogenetic Laboratory, Shenzhen Institute of Transfusion Medicine, Shenzhen Blood Center, Shenzhen, Guangdong, China., Zou HY; Immunogenetic Laboratory, Shenzhen Institute of Transfusion Medicine, Shenzhen Blood Center, Shenzhen, Guangdong, China.

Publikováno v: HLA [HLA] 2017 May; Vol. 89 (5), pp. 305-308. Date of Electronic Publication: 2017 Mar 01.

The role of HLA-A*33:01 in patients with cholestatic hepatitis attributed to terbinafine.

Autor: Fontana RJ; University of Michigan, Ann Arbor, MI, United States. Electronic address: rfontana@med.umich.edu., Cirulli ET; Duke University, Durham, NC, United States., Gu J; Duke University, Durham, NC, United States., Kleiner D; National Cancer Institute, Bethesda, MD, United States., Ostrov D; University of Florida College of Medicine, Gainesville, FL, United States., Phillips E; Vanderbilt University School of Medicine, Nashville, TN, United States., Schutte R; University of Florida College of Medicine, Gainesville, FL, United States., Barnhart H; Duke University, Durham, NC, United States., Chalasani N; Indiana University, Indianapolis, IN, United States., Watkins PB; University of North Carolina, Chapel Hill, NC, United States., Hoofnagle JH; National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, United States.

Publikováno v: Journal of hepatology [J Hepatol] 2018 Dec; Vol. 69 (6), pp. 1317-1325. Date of Electronic Publication: 2018 Aug 21.

HLA-B*14:02-Restricted Env-Specific CD8 ⁺ T-Cell Activity Has Highly Potent Antiviral Efficacy Associated with Immune Control of HIV Infection.

Autor: Leitman EM; Department of Paediatrics, University of Oxford, Oxford, United Kingdom ellen_leitman@hms.harvard.edu.; Harvard Medical School, Boston, Massachusetts, USA., Willberg CB; Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom., Tsai MH; Department of Paediatrics, University of Oxford, Oxford, United Kingdom., Chen H; Ragon Institute of MGH, MIT and Harvard, Boston, Massachusetts, USA.; Vaccine and Immunotherapy Center, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA., Buus S; Laboratory of Experimental Immunology, Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark., Chen F; Department of Sexual Health, Royal Berkshire Hospital, Reading, United Kingdom., Riddell L; Integrated Sexual Health Services, Northamptonshire Healthcare NHS Trust, Northampton, United Kingdom., Haas D; Departments of Medicine, Pharmacology, Pathology, Microbiology, and Immunology, Vanderbilt University School of Medicine, Nashville, Tennessee, USA., Fellay J; School of Life Sciences, Ecole Polytechnique Fédérale de Lausanne, Swiss Institute of Bioinformatics, Lausanne, Switzerland., Goedert JJ; Infections and Immunoepidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA., Piechocka-Trocha A; Ragon Institute of MGH, MIT and Harvard, Boston, Massachusetts, USA., Walker BD; Ragon Institute of MGH, MIT and Harvard, Boston, Massachusetts, USA.; HIV Pathogenesis Programme, The Doris Duke Medical Research Institute, University of KwaZulu-Natal, Durban, South Africa., Martin J; Department of Medicine, University of California San Francisco Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, California, USA., Deeks S; Department of Medicine, University of California, San Francisco, California, USA., Wolinsky SM; Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom.; Division of Infectious Diseases, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA., Martinson J; Department of Infectious Diseases and Microbiology, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, Pennsylvania, USA., Martin M; Cancer and Inflammation Program, Leidos Biomedical Research, Frederick National Laboratory for Cancer Research, Frederick, Maryland, USA., Qi Y; Cancer and Inflammation Program, Leidos Biomedical Research, Frederick National Laboratory for Cancer Research, Frederick, Maryland, USA., Sáez-Cirión A; Institut Pasteur, Unité HIV, Inflammation et Persistance, Paris, France., Yang OO; Department of Medicine, Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, USA.; AIDS Healthcare Foundation, Los Angeles, California, USA., Matthews PC; Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom.; Department of Infectious Diseases and Microbiology, Oxford University Hospitals NHS Foundation Trust, John Radcliffe Hospital, Oxford, United Kingdom., Carrington M; Ragon Institute of MGH, MIT and Harvard, Boston, Massachusetts, USA.; Cancer and Inflammation Program, Leidos Biomedical Research, Frederick National Laboratory for Cancer Research, Frederick, Maryland, USA., Goulder PJR; Department of Paediatrics, University of Oxford, Oxford, United Kingdom.; HIV Pathogenesis Programme, The Doris Duke Medical Research Institute, University of KwaZulu-Natal, Durban, South Africa.

Publikováno v: Journal of virology [J Virol] 2017 Oct 27; Vol. 91 (22). Date of Electronic Publication: 2017 Oct 27 (Print Publication: 2017).

Identification of HLA-B*14:41N in a NMDP Hispanic donor, selected for a patient of The Unrelated Mexican Donor Registry-DONORMO program in Mexico.

Autor: Alaez C; Department of Immunology and Immunogenetics, Instituto de Diagnóstico y Referencia Epidemiológicos, Secretary of Health, Mexico City, Mexico.; Fundación Comparte Vida, Mexico City, Mexico., Flores-A H; Department of Immunology and Immunogenetics, Instituto de Diagnóstico y Referencia Epidemiológicos, Secretary of Health, Mexico City, Mexico.; Fundación Comparte Vida, Mexico City, Mexico., Munguía A; Department of Immunology and Immunogenetics, Instituto de Diagnóstico y Referencia Epidemiológicos, Secretary of Health, Mexico City, Mexico., Gorodezky C; Department of Immunology and Immunogenetics, Instituto de Diagnóstico y Referencia Epidemiológicos, Secretary of Health, Mexico City, Mexico.; Fundación Comparte Vida, Mexico City, Mexico.

Publikováno v: Tissue antigens [Tissue Antigens] 2015 Sep; Vol. 86 (3), pp. 208-9. Date of Electronic Publication: 2015 Jul 20.